Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class II · Moderate risk

MakeSense PHARMA

CGMP Deviations

Terminated cGMP deviation Cherry Hill Sales Co. NDC 69020-205-28 D-0483-2017
Class I · High risk

Vancomycin Hydrochloride for Injection

Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.

Terminated Particulate / foreign matter Hospira Inc., A Pfizer Company NDC 0409-6510-01 D-0638-2017
Class II · Moderate risk

Calcipotriene Cream 0.0005%

Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling.

Terminated Chemical / undeclared Leo Pharma INC NDC 66993-877-61 D-0510-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0463-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0462-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-037-99 D-0461-2017
Class II · Moderate risk

Phenytoin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0460-2017
Class II · Moderate risk

Metoclopramide Oral Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0459-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-008-02 D-0457-2017
Class III · Low risk

Dexamethasone Elixir

Failed Impurities/ Degradation Specifications

Terminated Impurity / degradation Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals NDC 0603-1147-56 D-0438-2017
Class II · Moderate risk

Duopa (carbidopa and levodopa enteral suspension)

Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life

Terminated Stability / shelf life AbbVie Inc. NDC 0074-3012-07 D-0495-2017

Recalls by year